Prevention of Type 2 Diabetes Mellitus with Acupuncture: Protocol for a Systematic Review and Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2018 Dec 5

PMID 30508926

Citations 5

Authors

Liwei Shi

Ling Feng

Yanan Yang

Xiaowen Li

Meizhen Zhang

Yueying Zhang

Qing Ni

Affiliations

Soon will be listed here.

Abstract

Background: Prediabetes is prevalent and significantly increases lifetime risk of progression to type 2 diabetes mellitus (T2DM). Acupuncture has been increasingly used for prediabetes in China but its effect is unclear. We aim to assess the efficacy and safety of acupuncture in preventing or delaying incident diabetes among individuals with prediabetes.

Methods: The following 8 databases will be searched from inception to September 1, 2018: the Cochrane Central Register of Controlled Trials (CENTRAL) on the Cochrane Library, PubMed, Embase, Chinese National Knowledge Infrastructure database, Chinese Biomedical Literature database, Chinese Scientific Journal database, Wan Fang database, and Clinical Trials. The incidence of diabetes and regression toward normoglycemia will be accepted as the primary outcomes. The Cochrane Risk of Bias tool will be used to evaluate the methodologic quality of eligible studies. Meta-analysis will be performed by Review Manager 5.3.

Results: This study will provide a high-quality synthesis of current evidence of acupuncture in the prevention of T2DM from several aspects including the incidence of diabetes, regression toward normoglycemia, fasting plasma glucose, 2-hour plasma glucose level after a 75-g oral glucose tolerance test, glycosylated hemoglobin level, body mass index, and adverse drug events.

Conclusions: The conclusion of this review will provide evidence to judge whether acupuncture is an effective and safe intervention for prediabetes.

Prospero Registration Number: PROSPERO CRD42018111236.

Citing Articles

Diagnostic significance of serum PP4R1 and its predictive value for the development of chronic complications in patients with type 2 diabetes mellitus.

Li W, Peng L, Yang C, Chen G Diabetol Metab Syndr. 2021; 13(1):27.

PMID: 33750415 PMC: 7945353. DOI: 10.1186/s13098-021-00642-7.

Acupuncture Treatment Reduces Incidence of Parkinson's Disease in Patients With Depression: A Population-Based Retrospective Cohort Study in Taiwan.

Huang C, Lin M, Hsieh C Front Aging Neurosci. 2020; 12:591640.

PMID: 33343332 PMC: 7746549. DOI: 10.3389/fnagi.2020.591640.

Association of Acupuncture Treatment with Mortality of Type 2 Diabetes in China: Evidence of a Real-World Study.

Sui M, Xue L, Ying X Int J Environ Res Public Health. 2020; 17(21).

PMID: 33113774 PMC: 7663761. DOI: 10.3390/ijerph17217801.

Association of gene polymorphisms with the risk of developing type 2 diabetes mellitus in the Chinese Han population.

Cheng F, Liu L, Zhang H, Zhu Y, Li X, Li H Biosci Rep. 2019; 39(8).

PMID: 31375554 PMC: 6695499. DOI: 10.1042/BSR20190821.

Thyroid diseases increased the risk of type 2 diabetes mellitus: A nation-wide cohort study.

Chen R, Chen H, Man K, Chen S, Chen W, Liu P Medicine (Baltimore). 2019; 98(20):e15631.

PMID: 31096476 PMC: 6531080. DOI: 10.1097/MD.0000000000015631.

References

Zhao Z, Liu C, Zhang Q, Zhang B, Guo J, Yuan A . [Acupuncture Treatment Reduces Body Weight Possibly by Down-regulating Insulin and Leptin Resistance, and Up-regulating Soluble Leptin Receptor Level in Prediabetic Patients]. Zhen Ci Yan Jiu. 2018; 43(8):506-11. DOI: 10.13702/j.1000-0607.180184. View

Yang M, Li X, Liu S, Li Z, Xue M, Gao D . Meta-analysis of acupuncture for relieving non-organic dyspeptic symptoms suggestive of diabetic gastroparesis. BMC Complement Altern Med. 2013; 13:311. PMC: 4226258. DOI: 10.1186/1472-6882-13-311. View

Gerstein H, Santaguida P, Raina P, Morrison K, Balion C, Hunt D . Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007; 78(3):305-12. DOI: 10.1016/j.diabres.2007.05.004. View

Chiasson J, Josse R, Gomis R, Hanefeld M, Karasik A, Laakso M . Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002; 359(9323):2072-7. DOI: 10.1016/S0140-6736(02)08905-5. View

Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N . Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006; 368(9541):1096-105. DOI: 10.1016/S0140-6736(06)69420-8. View

Zinman B, Harris S, Neuman J, Gerstein H, Retnakaran R, Raboud J . Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Lancet. 2010; 376(9735):103-11. DOI: 10.1016/S0140-6736(10)60746-5. View

Torgerson J, Hauptman J, Boldrin M, Sjostrom L . XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2003; 27(1):155-61. DOI: 10.2337/diacare.27.1.155. View

Bethel M, Xu W, Theodorakis M . Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus. Diabetes Obes Metab. 2014; 17(3):231-44. DOI: 10.1111/dom.12401. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

10.

Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18):1343-50. DOI: 10.1056/NEJM200105033441801. View

11.

Cefalu W, Buse J, Tuomilehto J, Fleming G, Ferrannini E, Gerstein H . Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care. 2016; 39(7):1186-201. PMC: 4915559. DOI: 10.2337/dc16-0873. View

12.

Pan X, Li G, Hu Y, Wang J, Yang W, An Z . Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997; 20(4):537-44. DOI: 10.2337/diacare.20.4.537. View

13.

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

14.

Tabak A, Herder C, Rathmann W, Brunner E, Kivimaki M . Prediabetes: a high-risk state for diabetes development. Lancet. 2012; 379(9833):2279-90. PMC: 3891203. DOI: 10.1016/S0140-6736(12)60283-9. View

15.

DeFronzo R, Abdul-Ghani M . Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care. 2011; 34 Suppl 2:S202-9. PMC: 3632162. DOI: 10.2337/dc11-s221. View

16.

DeFronzo R, Tripathy D, Schwenke D, Banerji M, Bray G, Buchanan T . Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011; 364(12):1104-15. DOI: 10.1056/NEJMoa1010949. View

17.

Chen C, Wang H, Zhai X, Huang F, Wu D, Rong P . [Progress of Research on Mechanism of Acupuncture for Diabetes Mellitus]. Zhen Ci Yan Jiu. 2018; 43(9):601-5. DOI: 10.13702/j.1000-0607.180009. View

18.

Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q . Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017; 317(24):2515-2523. PMC: 5815077. DOI: 10.1001/jama.2017.7596. View

19.

Del Prato S, Bianchi C, Miccoli R, Penno G . Pharmacological intervention in prediabetes: considering the risks and benefits. Diabetes Obes Metab. 2007; 9 Suppl 1:17-22. DOI: 10.1111/j.1463-1326.2007.00766.x. View

20.

Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View